Jasper Therapeutics, Inc.
JSPR· Nasdaq
Released Aug 12, 2022, after the close
10-Q filed Aug 12, 2022, 43 days after period end · 0001213900-22-047382
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Net Income | -$10.40M | -$8.41M | -$3.43M |
| EPS Diluted | -$0.29 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Jasper Therapeutics, Inc. · CIK 1788028 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 12, 2022 · 43 d after period end